echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The third batch of high-value medical consumables collection and scanning of high-value medical consumables was organized

    The third batch of high-value medical consumables collection and scanning of high-value medical consumables was organized

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The third batch of high-value medical consumables was opened on the 27th and produced the results
    of the proposed selection.
    Focusing on orthopedic spine consumables, the average price of the selected products in this collection is reduced by 84%, and it is expected to save 26 billion yuan
    per year.
    The intended purchase volume in the first year was 1.
    09 million sets, accounting for 90%
    of the total demand for medical institutions nationwide.
     
    Following the coronary stent and orthopedic artificial joint, the "national team" of Jicai once again aims at the "hard task"
    of high-value medical consumables treatment.
    What are the highlights of this collection? When can patients use it? The reporter conducted an interview
    .
     
    Gao Xue, head of the centralized procurement team of the National Organization High-value Medical Consumables Joint Procurement Office, introduced that from the perspective of historical data collection, there will be about 1.
    2 million units of various spine surgeries in the country in 2021, and the sales amount of the spine consumables market will be nearly 35 billion yuan, accounting for more than 15% of the total amount of all high-value medical consumables market, and the bidding environment has been formed
    .
     
    "6,426 medical institutions across the country have filled in the procurement demand of 1.
    2 million sets, and a total of 171 enterprises have participated in this collection
    .
    " Gao Xue introduced that the collection scope covers more than 90% of the spinal consumables products in the market, fully meeting the needs of
    clinical treatment.
     
    In terms of price, the average price reduction of orthopedic spine consumables was 84%.

    Since orthopedic surgery requires enterprises to provide accompanying services such as clinical follow-up, this collection still adopts a separate accompanying service fee to ensure the stable supply and use of
    products.
     
    "The collection of orthopedic spine consumables is an important measure
    to control the inflated price and circulation chaos of orthopedic medical consumables.
    " Gao Xue said that this will help purify the industry ecology, promote the standardized and rational use of high-value medical consumables, and effectively reduce the burden of medical treatment for
    the masses.
     
    According to the type of surgery, surgical site, etc.
    to form a product system, the collection of orthopedic spine consumables is divided into 14 product system categories
    such as cervical anterior nail plate fixation and fusion system.
     
    "In terms of product characteristics, the spinal system is relatively complex
    .
    " Zhang Jie, an expert at the Joint Procurement Office of High-value Medical Consumables of the National Organization, said that in order to achieve full coverage of spine products, the collection was scientifically grouped and divided into 29 bidding units
    .
     
    In addition, in order to fully respect the clinical choice, the collection is independently reported by the medical institutions and the products are selected independently to meet the needs of clinical use and achieve "for use"
    .
     
    "The joint procurement of consumables has done a lot of basic work in the early stage to ensure the effectiveness and rationality of the reported volume, so that enterprises can better participate in it
    .
    " Lu Yun, a professor at the International Medical Business School of China Pharmaceutical University, introduced that enterprises can fully consider the production capacity of their products according to the reported volume, and properly arrange supply distribution and accompanying services
    .
     
    Different from the previous two batches of high-value medical consumables, the procurement cycle of orthopedic spine consumables is 3 years, calculated from the actual implementation date of the selection results in each region of the alliance, and the first-year agreement procurement volume is implemented
    from January to February 2023.
     
    "The expansion of the procurement cycle time has stabilized market expectations and made it more convenient for enterprises to arrange production plans
    .
    " Zhang Jie said that at the same time, it can also achieve the continuity of clinical product use, and ensure clinical treatment and follow-up services
    .
     
    This collection innovates the bidding rules, increases the two "resurrection mechanisms" between bidding units and 40% of the highest effective declared price, and promotes more enterprises to win the election and enhance the stability
    of expectations under the premise of ensuring fair competition, maintaining the intensity of competition, and removing inflated price space.
     
    According to reports, patients are expected to use the selected products
    after the price reduction in February 2023.
    The third batch of high-value medical consumables was opened on the 27th and produced the results
    of the proposed selection.
    Focusing on orthopedic spine consumables, the average price of the selected products in this collection is reduced by 84%, and it is expected to save 26 billion yuan
    per year.
    The intended purchase volume in the first year was 1.
    09 million sets, accounting for 90%
    of the total demand for medical institutions nationwide.
     
    Following the coronary stent and orthopedic artificial joint, the "national team" of Jicai once again aims at the "hard task"
    of high-value medical consumables treatment.
    What are the highlights of this collection? When can patients use it? The reporter conducted an interview
    .
     
    Gao Xue, head of the centralized procurement team of the National Organization High-value Medical Consumables Joint Procurement Office, introduced that from the perspective of historical data collection, there will be about 1.
    2 million units of various spine surgeries in the country in 2021, and the sales amount of the spine consumables market will be nearly 35 billion yuan, accounting for more than 15% of the total amount of all high-value medical consumables market, and the bidding environment has been formed
    .
     
    "6,426 medical institutions across the country have filled in the procurement demand of 1.
    2 million sets, and a total of 171 enterprises have participated in this collection
    .
    " Gao Xue introduced that the collection scope covers more than 90% of the spinal consumables products in the market, fully meeting the needs of
    clinical treatment.
     
    In terms of price, the average price reduction of orthopedic spine consumables was 84%.

    Since orthopedic surgery requires enterprises to provide accompanying services such as clinical follow-up, this collection still adopts a separate accompanying service fee to ensure the stable supply and use of
    products.
     
    "The collection of orthopedic spine consumables is an important measure
    to control the inflated price and circulation chaos of orthopedic medical consumables.
    " Gao Xue said that this will help purify the industry ecology, promote the standardized and rational use of high-value medical consumables, and effectively reduce the burden of medical treatment for
    the masses.
     
    According to the type of surgery, surgical site, etc.
    to form a product system, the collection of orthopedic spine consumables is divided into 14 product system categories
    such as cervical anterior nail plate fixation and fusion system.
     
    "In terms of product characteristics, the spinal system is relatively complex
    .
    " Zhang Jie, an expert at the Joint Procurement Office of High-value Medical Consumables of the National Organization, said that in order to achieve full coverage of spine products, the collection was scientifically grouped and divided into 29 bidding units
    .
     
    In addition, in order to fully respect the clinical choice, the collection is independently reported by the medical institutions and the products are selected independently to meet the needs of clinical use and achieve "for use"
    .
     
    "The joint procurement of consumables has done a lot of basic work in the early stage to ensure the effectiveness and rationality of the reported volume, so that enterprises can better participate in it
    .
    " Lu Yun, a professor at the International Medical Business School of China Pharmaceutical University, introduced that enterprises can fully consider the production capacity of their products according to the reported volume, and properly arrange supply distribution and accompanying services
    .
    Pharmaceutical and pharmaceutical enterprises
     
    Different from the previous two batches of high-value medical consumables, the procurement cycle of orthopedic spine consumables is 3 years, calculated from the actual implementation date of the selection results in each region of the alliance, and the first-year agreement procurement volume is implemented
    from January to February 2023.
    Procurement procurement
     
    "The expansion of the procurement cycle time has stabilized market expectations and made it more convenient for enterprises to arrange production plans
    .
    " Zhang Jie said that at the same time, it can also achieve the continuity of clinical product use, and ensure clinical treatment and follow-up services
    .
     
    This collection innovates the bidding rules, increases the two "resurrection mechanisms" between bidding units and 40% of the highest effective declared price, and promotes more enterprises to win the election and enhance the stability
    of expectations under the premise of ensuring fair competition, maintaining the intensity of competition, and removing inflated price space.
     
    According to reports, patients are expected to use the selected products
    after the price reduction in February 2023.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.